Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02308969Phase 1Completed
Phase 1, randomised, double-blind trial of Lysergide in schizophrenia, sponsored by University Hospital Basel. Primary endpoint: fMRI brain activity at 1 hour. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02308969.